MyFinsight
Home
Blog
About
Back
Cash Flow
Phio Pharmaceuticals Corp. (PHIO)
Phio Pharmaceuticals Corp. (PHIO)
source: myfinsight.com
Net (decrease)
increase in cash and cash...
-$4,035K
Accounts payable
$641K
(3661.11%↑ Y/Y)
Stock-based compensation
$278K
(195.74%↑ Y/Y)
Accrued expenses
$114K
(-45.45%↓ Y/Y)
Depreciation and
amortization
$1K
Net cash used in
operating activities
-$4,035K
(-5.77%↓ Y/Y)
Canceled cashflow
$1,034K
Net loss
-$4,138K
(-5.16%↓ Y/Y)
Prepaid expenses and
other assets
$931K
(464.24%↑ Y/Y)
Back